Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey

• Auteurs principaux: Akshika Sharma (Auteur), Brian Fix (Auteur), Andrew Hyland (Auteur), Maansi Bansal-Travers (Auteur), Amanda Quisenberry (Auteur), Richard O'Connor (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

IntroductionIQOS was authorized to be marketed as a reduced exposure product by the Food and Drug Administration in October 2020 during the global COVID-19 pandemic. Those who smoke may be more sensitive to reduced exposure marketing claims and may have an increased inclination toward IQOS use. We e...